Details for New Drug Application (NDA): 065303
✉ Email this page to a colleague
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 065303
Tradename: | CEFAZOLIN SODIUM |
Applicant: | Acs Dobfar |
Ingredient: | cefazolin sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 065303
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065303 | ANDA | Sagent Pharmaceuticals | 25021-100 | 25021-100-10 | 25 VIAL in 1 CARTON (25021-100-10) / 2.2 mL in 1 VIAL |
CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065303 | ANDA | Sagent Pharmaceuticals | 25021-101 | 25021-101-10 | 25 VIAL in 1 CARTON (25021-101-10) / 3 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Oct 22, 2008 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Oct 22, 2008 | TE: | AP | RLD: | No |
Complete Access Available with Subscription